Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

[Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].

Gao J, Cong HL, Mao YM, Liu Y, Zhang N, Chen Q, Liu T, Cui R.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Oct;30(5):553-8. doi: 10.3760/cma.j.issn.1003-9406.2013.05.010. Chinese.

PMID:
24078569
[PubMed - indexed for MEDLINE]
2.

[Effects of genetic variations of cholesteryl ester transfer protein on atorvastatin treatment efficacy and clinical outcomes in patients with coronary artery disease].

Gao J, Cong HL, Mao YM, Liu Y, Zhang N, Chen Q, Liu T, Cui RZ.

Zhonghua Yi Xue Za Zhi. 2013 Jul 23;93(28):2195-9. Chinese.

PMID:
24169327
[PubMed - in process]
3.

[Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].

Gao J, Mao YM, Cong HL, Liu Y, Zhang N, Chen Q, Liu T, Cui RZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 May;41(5):399-405. Chinese.

PMID:
24021123
[PubMed - indexed for MEDLINE]
4.

Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.

Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.

Cell Biochem Funct. 2009 Oct;27(7):452-7. doi: 10.1002/cbf.1593.

PMID:
19784962
[PubMed - indexed for MEDLINE]
5.

Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.

Blankenberg S, Rupprecht HJ, Bickel C, Jiang XC, Poirier O, Lackner KJ, Meyer J, Cambien F, Tiret L; AtheroGene Investigators.

J Am Coll Cardiol. 2003 Jun 4;41(11):1983-9.

PMID:
12798569
[PubMed - indexed for MEDLINE]
6.

Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.

Li J, Zhang L, Xie NZ, Deng B, Lv LX, Zheng LQ.

Genet Mol Res. 2014 Mar 24;13(1):2140-8. doi: 10.4238/2014.March.24.21.

PMID:
24737438
[PubMed - indexed for MEDLINE]
Free Article
7.

Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.

Poduri A, Khullar M, Bahl A, Sehrawat BS, Sharma Y, Talwar KK.

DNA Cell Biol. 2010 Oct;29(10):629-37. doi: 10.1089/dna.2009.1008.

PMID:
20578904
[PubMed - indexed for MEDLINE]
8.

Cholesteryl ester transfer protein (CETP) -629C/A polymorphism and it's effects on the serum lipid levels in metabolic syndrome patients.

Akbarzadeh M, Hassanzadeh T, Saidijam M, Esmaeili R, Borzouei Sh, Hajilooi M, Mahjub H, Paoli M.

Mol Biol Rep. 2012 Oct;39(10):9529-34. doi: 10.1007/s11033-012-1817-3. Epub 2012 Jun 23.

PMID:
22729881
[PubMed - indexed for MEDLINE]
9.

HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment.

Dullaart RP, van den Berg G, van der Knaap AM, Dijck-Brouwer J, Dallinga-Thie GM, Zelissen PM, Sluiter WJ, van Beek AP.

Eur J Endocrinol. 2010 Feb;162(2):227-34. doi: 10.1530/EJE-09-0742. Epub 2009 Nov 19.

PMID:
19926784
[PubMed - indexed for MEDLINE]
Free Article
10.

Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):349-54. doi: 10.2165/11632570-000000000-00000.

PMID:
22900989
[PubMed - indexed for MEDLINE]
11.

An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group.

J Clin Endocrinol Metab. 2006 Sep;91(9):3382-8. Epub 2006 May 9.

PMID:
16684835
[PubMed - indexed for MEDLINE]
12.

Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.

Fu Q, Li YP, Gao Y, Yang SH, Lu PQ, Jia M, Zhang LR.

Eur J Clin Pharmacol. 2013 Jun;69(6):1269-74. doi: 10.1007/s00228-012-1453-9. Epub 2012 Dec 22.

PMID:
23263738
[PubMed - indexed for MEDLINE]
13.

On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).

Khera AV, Wolfe ML, Cannon CP, Qin J, Rader DJ.

Am J Cardiol. 2010 Aug 15;106(4):451-6. doi: 10.1016/j.amjcard.2010.03.057.

PMID:
20691300
[PubMed - indexed for MEDLINE]
14.

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.

van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM; DALI Study Group.

Diabetes Care. 2003 Apr;26(4):1216-23.

PMID:
12663600
[PubMed - indexed for MEDLINE]
15.

CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.

Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.

Clin Sci (Lond). 2006 Nov;111(5):325-31.

PMID:
16822236
[PubMed - indexed for MEDLINE]
Free Article
16.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
[PubMed - indexed for MEDLINE]
17.

I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease.

Ghatreh Samani K, Noori M, Rohbani Nobar M, Hashemzadeh Chaleshtori M, Farrokhi E, Darabi Amin M.

Iran Biomed J. 2009 Apr;13(2):103-8.

PMID:
19471550
[PubMed - indexed for MEDLINE]
18.

The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group.

J Clin Endocrinol Metab. 2005 Jul;90(7):4198-204. Epub 2005 Apr 19.

PMID:
15840744
[PubMed - indexed for MEDLINE]
19.

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

PMID:
18640465
[PubMed - indexed for MEDLINE]
20.

[Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].

Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.

Z Kardiol. 2004;93 Suppl 4:IV16-23. German.

PMID:
15085362
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk